Global Pelvic Organ Prolapse Devices Market

Pelvic Organ Prolapse Devices Market Insights

Pelvic organ prolapse takes place when the organs near the pelvic region descend from their position and slip into the vagina. The major cause of the slip of these organs is the weakened tissues and muscles in that area. However, a prolapse isn't hazardous, however, it can cause torment and inconvenience. Treatment to address this kind of prolapse includes behavioral therapy, such as doing Kegel practices intended to reinforce the pelvic floor muscles, or medical therapy, of embedding a little plastic gadget called as pessary into the vagina to offer help for the hanging organs, and drug treatment method. The rising prevalence of this disorder amongst geriatric as well as the younger population will propel the uptake of the surgical devices for treatment. Also, extensive awareness activities going live for helping women understand the importance of POP and the continuous launch of technically advanced products to treat POP will help the market grow during the forecast time frame.

Pelvic Organ Prolapse Devices Market: By Product Type

The segments of the product of POP are vaginal prosthetic devices and vaginal mesh. Furthermore, vaginal mesh is bifurcated into Transvaginal & Sacrocolpopexy mesh. The vaginal prosthetic device or a pessary will be the major shareholder in the POP devices market considering the high effectiveness of this device. Moreover, this device has recorded a success rate of 40-75% for stages 3 & 4 of prolapse. This has also indicated that the pessary market will reach not only to the geriatric female patient population but also to the female patients of the age group 20 to 49.

Pelvic Organ Prolapse Devices Market: By Treatment Type

Surgical and nonsurgical treatment options are available when it comes to combat POP in both older and younger female patients. However, due to the rising preference for minimally invasive treatment options, most of the patients opt for up taking pessary implants in their vagina for holding the slipping organs. Hence the non-surgical treatment protocol is the major shareholder in the segment during the forecast period.

Pelvic Organ Prolapse Devices Market: By Patient Age Group

According to the patient’s age, the POP can be defined in 7 segments namely, 20-29, 30-39, 40-49, 50-59, 60-69, 70-79, and Above 80. The incidence rate of POP in the age group is seen as the highest in the 40-49 age group. This can be attributed to the drastic alteration in lifestyle of the female population about post-pregnancy complications and menopause. Hence the market segment of the 40-49 age group will hold the highest market share in the forecast period.

Pelvic Organ Prolapse Devices Market: By End-User

Gynecology clinics, general & nursing hospitals, and ASCs are the major end-users of the POP devices. However, general hospitals will hold the major share in the market followed by the gynecology clinics or private setups that address the treatment of POP in most middle-aged patients.

Pelvic Organ Prolapse Devices Market: By Region

The geographical study of the pelvic organ prolapse devices market states that the Asia-Pacific will be the fastest-growing regional segment and North America will be the dominant region as per market value and volume is concerned. The middle to low-income countries has been a major contributor to the incidence rate across the globe. The incidence rate is around 20-25% making them the fastest-growing segment. On the other hand, NA holds a prominent position mainly due to favorable insurance policies behind using the pessary or undergoing surgical procedures for POP.

Pelvic Organ Prolapse Devices Market Share and Competitor Analysis

Major companies in the market are MEDesign Ltd., Ethicon USA, LLC., Coloplast Ltd., Arabin GmbH and Co., MedGyn Products Inc., Boston Scientific Corporation, Panpac Medical Corp., Personal Medical Corp., CooperSurgical Inc., Brad Medical, Integra LifeSciences, IncoStress, Contipi, The Trendline Group, and Arms Medical among others.

Please note: This is not an exhaustive list of companies profiled in the report.

In November 2019, Contipi launched a minimally invasive non- surgical product device for women suffering from pelvic organ prolapse. This device has also bagged the 510k clearance for the sale in the major parts of the world.

In April 2019, the US FDA announced that all the manufacturers and producers of all surgical mesh which are designed specifically for transvaginal repair to stop its marketing and sales activity in the US for safety purposes.

Check the Press Release on Global Pelvic Organ Prolapse Devices Market Report